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OBJECTIVE:  T  lymphocytes  have  a  central  regulatory
role in the pathogenesis of asthma. The objective of
this  study  was to  characterize  immunologically  the
activation stage of asthma and the functional profile
of lymphocytes from induced sputum, with particular
emphasis on g d T cells.
Methods:  Induced  sputum  was  collected  from  10
patients with acute exacerbation of asthma, and from
healthy controls. The expression of activation mark-
ers on freshly isolated induced sputum lymphocytes
and T-cell subsets was analyzed by double immuno-
fluorescent staining and flow cytometry. Fas ligand
(FasL) was determined by reverse transcriptase-poly-
merase chain reaction analysis. The phenotype of g d
T-cell  subpopulations  was  tested  by  A13  and  BB3
monoclonal antibodies. In this context, the functional
profile  of  g d T  cells  was  tested  in  a  chromium
releasing test.
Results: A significantly decreased proportion of a b T
cells and an increased proportion of g d T cells, CD56+
cells  and  CD8+ g d T  cells  were  found  in  asthma
patients  compared  with  healthy  controls.  In  asth-
matic  patients,  there  is  a  significantly  increased
proportion  of  T  cells  expressing  CD69  and  CD25
antigen. After stimulation of g d T cells, an increased
expression of intracellular tumour necrosis factor-a ,
interleukin (IL)-4 and IL10 cytokines were found at
higher  levels  than  controls.  Interferon-g was
observed  at  similar  levels  in  asthma  patients  and
healthy  controls.  Freshly  isolated  T-cell  receptor
(TCR) g d
+ cells exhibited an increased percentage of
FasL in our patient group. FasL mRNA was detected in
TCR g d
+ cells before and after IL2 stimulation. TCR
g d
+ cells  were cytotoxic  against the K562  cell  line.
This  natural  killer  activity  was  mediated  by  the
A13-positive subpopulation.
Conclusion: The presence of cytokines producing g d
cells  in  induced  sputum  of  asthmatic  patients  is
consistent with regulatory activities. These cells dis-
play also cytotoxic function.
Key words: Asthma, gd T cells, Inflammation, Fas ligand,
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Introduction
Asthma is characterized by a chronic mucosal inflam-
mation of the airways, which underlies the two main
clinical features of the disease: bronchial constriction
and bronchial hyper-responsiveness. The mechanisms
regulating  airway  function  are  complex  and  still
poorly  understood.  In  diseases  such  as  asthma,
involvement of immune-dependent mechanisms has
been suggested in causing changes in airway respon-
siveness  to bronchoconstrictors. The role of T lym-
phocytes  in  the  pathogenesis  of  asthma  has  been
emphasized  in  recent  years.  T  lymphocytes  are
increased in asthma and are activated in the bronchial
mucosa  of  the  asthmatics.1 Through  secretion  of
cytokines, CD4+T lymphocytes actively participate to
the inflammatory process found in asthma.2 gdT cells
can regulate airway function in an abT cell-independ-
ent  manner,  identifying  them  as  important  cells  in
pulmonary  homeostasis.  gd T  cells  can  produce T
helper (Th)2 cytokines, which suggests their possible
participation in  the  development of Th2  responses
and,  thus, in  the  onset  of  pulmonary  allergic  reac-
tions.2 In  a  model of pulmonary  allergic  inflamma-
tion, genetically gdT-cell-deficient mice exhibited low
specific immunoglobulin (Ig)E and interleukin (IL)-5
release,  and  diminished T-cell  infiltration  compared
with wild-type mice. These response were restored by
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for inducing IL-4 secretion and Th2-mediated airways
inflammation.3Activation of the regional gdT cells to
produce  lymphokines  would  then  promote  non-
specific  inflammation  and  macrophage  activation,
providing  a  degree  of  non-specific  resistance.4,5
However, the precise role of gdT lymphocytes in the
human lung and lower airways6 is not yet known. gd
T cells home in the epithelial surface,7,8 and induced
sputum  should  be  representative  for  gd T  cells  in
inflamed bronchi. Numerous effector functions have
been attributed to gd cells,8 and we are only  now
uncovering their potentially important contributions
to immune responses.
The objective of this investigation was to determine
whether there is a shift in the proportion of gdT cells
and their function in induced sputum of patients with
asthma as compared with healthy controls.
Patients and methods
Patients
Induced  sputum  samples  were  collected  from  10
successive patients with allergic asthma. All were in-
patients, admitted by  the emergencies for  an acute
exacerbation of dyspnea (mean age, 38.5 years; range,
22–80 years). Patient asthma was classified according
to National Heart, Lung and Blood Institute criteria9as
persistent mild-to-moderate asthma. The sample was
obtained  the  day  after  their  admission. A  precise
history of the patient was subsequently obtained and,
after recovery functional respiratory tests, skin tests
and serum IgE dosages were realized. Patients were
excluded  due  to  the  following:  concomitant  infec-
tious  pneumonia,  tuberculosis,  interstitial  lung  dis-
eases,  bronchiectasis,  lung  cancer,  and  associated
acute pathologies: cardiac, renal, liver, or neurological
diseases. Ten healthy subjects (mean age, 28.7 years;
range,  22–36  years),  who  had  normal  pulmonary
radiographs and showed no clinical signs of respira-
tory  diseases,  acted  as  controls.  Informed  consent
was  obtained  from  all  the  patients. The  study  was
approved by the local Ethics Committee.
Sputum
Sputum  induction  and  processing  were  realized
following  the  method  recently  reported.10 Briefly,
after  the  inhalation  of  salbutamol  (2  ´ 200mg),
subjects  were  asked to  inhale  sterile, pyrogen-free,
hypertonic saline in increasing concentrations for a
duration  of  10min.  Most  patients  were  able  to
expectorate  an  adequate  sample  (5ml  and  more)
within  the  first  10min. The  cell  pellet  was  resus-
pended  in  phosphate-buffered  saline  (PBS)  in  a
volume  equal  to  the  sputum  plus  dithiothreitol
solution volume. Total cell counting was carried out in
a  haemocytometer  and  the  cell  concentration was
adjusted  to  1.0  ´ 106 cells/ml.  Cytospins  were
prepared  by  adding  75ml  of  cell  suspension  into
Shandon II cytocentrifuge  cups  (Shandon Southern
Instruments, UK) and spun for 8min at 500rpm.
Monoclonal antibodies
Monoclonal antibodies (MoAbs) against human CD69,
CD40 ligand and gdT-cell receptor (TCR) were all from
Coulter Electronics, Luton, UK. Fluorescein isothiocya-
nate  (FITC)-labelled  and  unlabelled  MoAbs  against
human ab TCR (clone WT31), FITC-labelled MoAbs
against human gdTCR, and PE-labelled MoAbs against
human CD4 and CD8 were all purchased from Becton
Dickinson (Oxford, UK). MoAbs against human CD25
and FITC-labelled MoAbs against human CD56 were
purchased  from  Immunotech  (Marseille,  France).
Phycoeritrin (PE)-labelled or FITC-labelled goat anti-
mouse immunoglobulin,  the F(ab)2 fragments, were
purchased from Dako (Marseille, France). MoAbs anti-
BB3 (Vd2) and anti-A13 (Vd1) were used to determine
anti-gdTCR subpopulations. Optimal dilutions for use
in immunofluorescence procedures were established
in preliminary experiments.
Double immunofluorescence staining
To  analyse  expression  of  activation  markers  on
induced sputum lymphocytes and T-cell subsets, 2 ´
103 freshly isolated cells in 100ml of staining buffer
(PBS with 1% foetal calf serum (FCS) and 0.02% NaN3)
were incubated with 5ml of MoAbs against CD25 or
CD40L, or 30ml of MoAbs against CD69, for 45min
on ice. Then the cells were washed twice with 1ml of
staining  buffer  at  160  ´ g for  5min  at  4°C,  and
subsequently  incubated  with  100ml  of  PE-labelled
goat anti-mouse immunoglobulin,  diluted 1:100,  for
30min  on  ice,  followed  by  washes  as  earlier.
Unbound goat antibody sites were blocked by incu-
bating the cells  with 100ml of PBS containing 10%
normal human  serum  for  10min  on ice before the
cells  were  incubated  with  10ml  of  FITC-labelled
MoAbs against ab or gd TCR or FITC-labelled control
mouse  IgG1. The cells were washed as before  and
fixed  in  200ml  of  1% paraformaldehyde in  staining
buffer.  For  co-receptor measurements,  2 ´ 103cells
were incubated for 45min on ice with 10ml of PE-
labelled  MoAbs  against  CD4  or  CD8  or  PE-labelled
control  mouse  IgG1,  and  10ml  of  FITC-labelled
antibodies against CD56, abTCR, or gdTCR or FITC-
labelled control mouse IgG1.
Cell culture
Cells  were  washed  in  RPMI  medium  and  either
stained immediately or cultured before further analy-
sis.  Cells  were  cultured  in  24-well  plates  at  a
concentration of  1 ´ 103 cells/ml in RPMI medium
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cultured  in  the  presence  of  phytohaemagglutinin
(PHA) (Sigma Chemical Co., St Louis, MO, USA) at a
concentration  of  5mg/ml  or  in  the  presence  of
phorbol myristrate (PMA) (Sigma Chemical Co.) at a
concentration  of  50ng/ml  in  combination  with
1mmol/ml  of  ionomycin  (Sigma  Chemical  Co.)  at
10mg/ml.  To  prevent  secretion  of  the  cytokines,
brefeldin A  at  10mg/ml  (Sigma  Chemical  Co.)  was
added during the last 4h of the incubation. Maximum
production of interferon-g (IFN-g) and tumour necro-
sis  factor-a (TNF-a)  was  observed after  stimulation
with PMA in combination with ionomycin, whereas
PHA was more effective in inducing production of IL-
4 and IL-10.
Intracellular cytokines
Stimulated  and  unstimulated  cells  were  stained  in
parallel  by  incubating  2  ´ 103 cells  in  100ml  of
staining buffer for 45min on ice with 10ml of MoAbs
against a gd TCR, diluted 1:10, followed by 100ml of
FITC-labelled  goat  anti-mouse  immunoglobulin,
diluted 1:100,  for 30min on ice. Before the second
staining,  the  cells  were  fixed  in  200ml  of  4%
paraformaldehyde in PBS for 10min on ice and then
unbound goat antibody sites were blocked by incubat-
ing the cells with 100ml of PBS containing 5% normal
human serum and 5% normal mouse serum for 10min
on ice. To permeabilize the cells, 0.1% saponin was
included in the staining buffer  used for subsequent
incubations and washing. The cells were incubated
with 10ml of PE-labelled antibodies against cytokines
(IL4,  IL-10, TNF-a or  IFN-g)  or  PE-labelled  control
mouse IgG1, diluted 1:20, for 45min on ice, washed
and then fixed in 400ml of 1% paraformaldehyde in
staining buffer.
Flow cytometric analysis
Fluorescent  labelled  cells  were  analysed  by  a  flow
cytometry (FACScan; Becton Dickinson). Before each
set of data analysis, the machine was standardized for
data reproducibility using fluorescent labelled beads
(Coulter). Ten  thousand cells  were  collected. Plots
showing the size and granularity were used to select
the lymphocyte population for further analysis. Cells
stained with isotype-matched antibody or a second
antibody alone were used as controls, with positive
cells set at 0.5%. For intracellular cytokine analysis,
unstimulated cells were used as negative controls.
Natural killer activity
gd T-cell cytotoxic activity was tested against K562
target cells in a standard 4-h 51Cr-release assay. Briefly,
gd T cells in RPMI-1640 containing 10% FCS at 37°C
for 48h were used as effector cells, incubated with IL-
2,  anti-Fas,  anti-BB3  or  anti-A13  monoclonal  anti-
bodies.  The  cells  were  washed  and  assayed  for
cytotoxic activity against 51Cr-labelled target cells in a
total volume of 200ml in 96-well U-bottom microtitre
plates. After 4h, 100ml of supernatant were harvested
and  counted  in  a  gamma-counter  (LKB,  Bromma,
Sweden). Maximum and spontaneous releases were
determined  by  incubating  51Cr-labelled  target  cells
with  1%  Triton-X-100  (Sigma  Chemical  Co.)  or
medium alone, respectively. All determinations were
made  in  duplicate,  and  effector:target  (E:T)  ratios
ranged from 10:1. The percentage of specific lysis was
determined as follows: [(experimental release – spon-
taneous  release)/(maximum  release  –  spontaneous
release)] ´ 100. The  spontaneous  release  was  rou-
tinely less than 10% of the maximum release.
Statistical analysis
Results are expressed as mean ± standard error of the
mean  for  each  study  group.  Significance  was  eval-
uated  using  Student’s  t-test  for  non-paired  samples
with unequal variance, with p < 0.05 being regarded
as significant.
Results
Expression of ab TCR, gd TCR, CD56, CD4 and
CD8 on lymphocytes and T-cell subsets in
induced sputum cells from patients with
asthma and from healthy controls
The expression of ab TCR, gd TCR, CD56, CD4 and
CD8 on lymphocytes was analysed in induced sputum
from patients with acute exacerbation of asthma and
from healthy controls (Fig. 1). A significant decrease
in the proportion of lymphocytes expressing abTCR
and  a  significant  increase  in  the  proportion  of
lymphocytes expressing gdTCR or CD56 were found
gd T cells in asthma
Mediators of Inflammation · Vol 11 · 2002 115
FIG. 1. Expression of TCR ab, TCR gd, CD4, CD8, and CD56,
analysed  by  immunofluorescence  staining  and  flow  cyto-
metry. Results  are expressed as percentage positive cells,
shown as mean ± standard error of the mean for induced
sputum from 10 asthmatic patients with acute exacerbation
of  asthma  and  from  10  healthy  controls.†  Significantly
different between asthmatic patients and healthy controls (p
< 0.001); N.S., not significantly different.in asthma patients (59.4 ± 3.4%, 16.2 ± 1.3%, and 14.2
± 2.7%, for ab TCR, gd TCR and CD56, respectively)
compared with healthy controls (72.5  ±  2.6%,  p <
0.05; 7.4 ± 0.5%, p < 0.005; and 9.2 ± 0.4%, p < 0. 005,
for  ab TCR,  gd TCR  and  CD56,  respectively),  as
shown in Fig. 1.
The proportion of CD4+ lymphocytes was raised in
induced sputum of patients with asthma (52 ± 7.8%,
p < 0.01) compared with controls (42 ± 3.2%). There
was no difference in the percentage of CD8+ lympho-
cytes between asthma patients (36.5 ± 8.2%, p < 0.01)
and  the  control  group  (34  ±  10.4)  in  induced
sputum.
When the T-cell subsets were analysed separately, a
significantly  raised  proportion  of  gd T  cells  from
asthma  patients  (10.5  ±  1.2%)  co-expressed  CD8
compared with gdT cells from healthy controls (4.9 ±
3.4%, p < 0.01) (Fig. 1).
We analyzed the TCR gd+ cells subsets (A13+ cells
and BB3+ cells). The significant increase in induced
sputum  of TCR  gd+ cells  in  patients  with  asthma,
compared with normal controls, was exclusively due
to the increase of the A13+ subset (asthma patients:
A13+ cells,  26.5  ±  4.2%;  BB3+ cells,  2.8  ±  0.4%
versus control: A13+ cells, 4.4 ± 1.2%; BB3+ cells, 5.2
± 1.2%).
Expression of activation markers on T cells in
induced sputum from patients with asthma
A significantly  increased percentage of  CD69+ lym-
phocytes was observed in the induced sputum from
asthmatic patients (15.3 ± 2.4%) compared with the
controls (6.5 ± 1.7%, p < 0.01).
An increase was observed for the proportion of gd
T  cells  expressing  CD25  in  patients  with  asthma
(12.3  ±  2.6%,  p <  0.01)  compared  with  healthy
controls (2.5  ± 1.8%).
Expression of intracellular cytokines on gd T
lymphocytes in induced sputum from patients
with asthma
The expression of intracellular IL-4, IL-10, IFN-g and
TNF-a in the gdT-cell subset was analysed in induced
sputum  from  patients  with  acute  exacerbation  of
asthma and from healthy controls (Fig. 2).
Before stimulation, gdT cells did not express any of
the  cytokines  analysed.  However,  after  appropriate
mitogen stimulation of gd T cells, there was expres-
sion  of  intracellular  TNF-a,  IFN-g,  IL-4  and  IL-10
cytokines (Fig. 2). A significantly increased proportion
of gdT cells from asthma patients could be induced to
express TNF-a after PHA stimulation compared with
controls (p < 0.05). A similar proportion of gdT cells
expressing  IFN-g was  observed  for  the  asthma
patients and the controls. The frequency of gdT cells
expressing IL-4 or IL-10 was significantly increased in
asthma patients when compared with induced spu-
tum from healthy controls.
Phenotype and expression of Fas ligand mRNA
in TCR gd+ cells
Freshly isolated TCR gd+ cells isolated from induced
sputum  exhibited  a  high  percentage  of  Fas  ligand
(FasL) in patients with acute exacerbation of asthma
(14.7 ± 4.5%, p < 0.01), when compared with healthy
controls (3.6 ± 2.8%).
When  TCR  gd+ cells  from  asthma  patients  and
healthy controls were IL-2-activated, they expressed
FasL mRNA (Fig. 3). This finding support the view that
TCR gd+ cells from asthma patients have the ability to
lyse Fas-expressing targets by producing FasL, without
IL-2 activation.
Functional profile of TCR gd+ cells in induced
sputum
Isolated induced  sputum TCR  gd+ cells  from  eight
patients  with  asthma  compared  with  five  healthy
A. Hamzaoui et al.
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FIG. 2. Expression of TNF-a, IFN-g, IL-4 and IL-10, on induced
sputum  gd T  cells  in  asthmatic  patients  and  in  healthy
controls  analysed  by  double  immunofluorescent  staining
and flow cytometry.† Significantly different between asth-
matic  patients and  healthy controls  (p <  0.001); N.S.,  not
significantly different.
FIG. 3. Expression of FasL mRNA on TCR gd
+ cells in induced
sputum from patients with asthma. The expression of FasL
and b2 microglobulin in freshly isolated TCR gd
+ cells (lane 1
and lane 3), and TCR gd
+ cells activated with IL-2 (250U/ml)
(lane 2 and lane 4), were analysed by reverse transcriptase-
polymerase  chain  reaction  as  described  in  Materials  and
methods.  Representative  data  from  two  experiments  are
shown.controls  were  tested  for  their  cytotoxic  activity
against K562 cell line at a ratio of 10:1 (E:T) (Fig. 4).
Fresh TCR  gd+ gave  low  but  detectable  cytotoxic
activity in asthma patients (8 ± 2.5%), which was < 5%
in healthy controls. When TCR gd+cells were cultured
with IL-2 for  3 days, cytotoxic activity appeared in
healthy controls (7.5 ± 4%) and increased significantly
in patients with asthma (23 ± 2.4%, p < 0.001).
Cytotoxic activity  of  IL-2-activated TCR  gd+ cells
was  abolished when  anti-FasL  was  added. Cytotox-
icity was lower than 5% both in asthmatic patients
and in healthy controls.
When IL-2-activated TCR gd+ cells were incubated
with  anti-BB3  monoclonal  antibody,  natural  killer
(NK) activity decreased, compared with IL-2-activated
TCR gd+ cells alone in asthmatic patients, but did not
reach  statistical  significance.  Anti-BB3  monoclonal
antibody  did  not  reduce  the  lytic  activity  of  IL-
2-activated TCR gd+ cells in healthy controls.
However,  the  addition  of  anti-A13  monoclonal
antibody  to  activated-TCR  gd+ cells  induced  the
abolition of cytotoxic activity both in asthmatics and
in healthy controls, which was lower than 5%. Lytic
activity in healthy controls was identical to TCR gd+
cell activity alone. In asthmatics, anti-A13 monoclonal
antibody inhibited NK activity at a lower level than
inactivated TCR gd+ cells.
Discussion
We have observed a reduced number of ab TCR and
an increased number of gdT lymphocytes in induced
sputum  from  patients with  acute  asthma exacerba-
tion. Studies revealed that the expression of ab TCR
by alveolar T cells was decreased as compared with
autologous  blood  T  cells,  in  a  wide  variety  of
pathological  and  physiological  conditions  of  the
lung.11 The expression of CD3 antigen by alveolar T
cells  is  also  likewise  reduced  in  health  and  dis-
ease.12,13 We analysed the activation status, cytokine
production and  cytotoxic function  of  gd T cells in
induced  sputum  compared  with  those  found  in
healthy controls.
The proportion of gd T cells in BAL from patients
with  asthma was  expanded as has been  shown  by
Molfino  et  al.4 Asthma  patients  had  a  raised  per-
centage of CD8+ T cells among the cells expressing
the  gd TCR. This  suggests  a role  for  CD8+ cells  in
asthma  disease,  with  the  gd T  cells  being  more
prominent  in  asthma-induced  sputum.  It  has  been
reported  that,  in  allergic  asthmatic  subjects, T-cell
expansion  preferentially  emerges  in  the  lung  CD8+
T-cell subset in BAL, with direct attention to the role
of  CD8  T  lymphocytes  in  the  pathogenesis  of
asthma.11 Furthermore,  we  reported  a  significant
increase in the proportion of CD56+ cells in sputum
from asthma patients compared with controls. CD56
is one of the markers of NK cells. The involvement of
cytotoxicity in asthma pathways has been suggested,
by the finding of induced sputum gd T cells express-
ing  increased  percentages  of  CD56  and  CD8
markers.
Studies that aimed at determining expansion of the
gd T-cell  population  in  the  human  lung  are scarce.
Groh et al.14 did not detect gd T cells in foetal and
adult  lung  using  MoAbs. Walker  et  al.15 found  no
difference  in  the  number  of  gd T  cells  between
asthmatic and control subjects, which is in  accord-
ance with the findings of Fajac et al.16 in the normal
bronchi mucosa and in alveolar parenchyma.17 Con-
versely,  Spinozzi  et  al.18 reported  an  increased
number of gdT cells in asthmatic patients, which is in
accordance with our finding. Agostini et al.19recently
reported that Vd2+ T  cells  comprise  approximately
70% of the gd T cells in the normal lung. It has been
reported  that  the  number  of  gd T  lymphocytes  in
bronchi biopsies of asthmatics was not different from
controls.20These different results might be due to the
diversity  of  the  patients  studied,  since  the  airway
inflammation  may  vary  with  the  severity  of  the
disease. An increased number of gdT cells were found
in the nasal mucosa of patients with perennial allergic
rhinitis.21 gdT cells may exist either in deep layers of
the airway wall or in some distal bronchi. It is also of
interest that the presence of gd T cells appears to be
restricted  to  early  stages  of  infection  or  inflamma-
tion.22,23The increased gd T cells found in this work
could  be  associated  with  the  acute  symptoms
observed in our patients and to the use of induced
sputum, which describes a real representative finding
of the cellularity distribution in the proximal bronchi.
Yet  in  none  of  the  bibliographic  studies  was  the
functional status of such cells investigated.
gdT cells are considered to be pre-activated T cells
in  BAL  of  asthma  patients.4 A  classical  way  of
analysing T-cell activation is to measure the upregula-
tion  of  CD25,  the  a-chain  of  the  IL-2  receptor.  In
asthma  patients,  it  was  clear  that  the  gd T-cell
population was in an activated stage, whereas the ab
gd T cells in asthma
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FIG. 4. Cytotoxic activity mediated by TCR gd
+ cells against
K562 target cells. TCR gd
+ cells were purified from induced
sputum from asthmatic patients and from healthy controls.
The values represent the mean of triplicate assays at a 10:1
(E:T) ratio.† Cytotoxic activity of asthmatics was significantly
different  from  healthy controls  (p <  0.001); N.S.,  not  sig-
nificantly different.T-cell subset showed no increase in CD25 expression
compared with  controls. This  observation indicates
that the gdT cells in sputum from asthma patients had
already been activated. Whether the activation occurs
as a result of the disease or whether the activated gd
T cells play a direct role in the pathogenesis needs to
be elucidated.
It was of interest to investigate the expression of
another activation molecule on the T cells that could
interact with the various cells and epithelial proteins
in the bronchial mucosa. Therefore, we analysed the
expression  of  CD69.  Our  study  found  a  raised
percentage of gd T cells expressing CD69 in asthma
patients  compared  with  controls.  CD69,  an  early
activation marker, is involved in lymphocyte prolifera-
tion, and functions as a signal-transmitting receptor in
T and B lymphocytes, NK cells and platelets.24 The
ligand for CD69 is still unknown.
Unbalanced expression of Th1 or Th2 cytokines has
been associated with asthma and may play a role in
human inflammatory diseases. Previous studies ana-
lysing  cytokines  in  asthma have  not  been  directed
against individual cells, but have analysed cytokines in
serum  or in supernatants from  bulk  populations of
peripheral blood, BAL, or induced sputum.3,25,26The
development of a method of  detecting intracellular
cytokines  by  flow  cytometry  meant  that  it  was
possible to study the contribution of individual cells,
in  a  heterogeneous  cell  population,  to  specific
cytokine production. Asthma patients group had an
increased sputum proportion of gd T cells secreting
TNF-a when compared with healthy controls. TNF-a
is  another  cytokine  involved  in  inflammation  that
plays a major role in induction of adhesion molecules
and inflammatory cytokine production.27 It is mainly
produced by activated monocytes and macrophages.
Our results show, however, that in asthma patients a
substantial  proportion  of  gd T  cells  is  able  to
participate in TNF-a production. The observation of
an increased proportion of gdT cells that secrete TNF-
a provides an interesting finding in asthma.
Our  results  reported  increased  IL-4  and  IL-10
intracellular cytokines expression. This corroborates
the recent inflammatory response in induced sputum
in patients with acute exacerbation of asthma.3Thus,
Th2 cytokine-producing cells of the gd TCR type are
present  in  asthmatic  sputum  patients.  These  Th2
cytokine-producing cells may be upregulated as part
of the general inflammatory response in the asthmatic
bronchi.  Th1  cytokines  were  at  a  normal  level
compared with controls.
Our findings reported a significant increase of gdT
cells associated with a non-specific lysis against the
K562  cell  line.  One  of  the  mechanisms  of  cell-
mediated  cytotoxicity  established  is  the  Fas/FasL
system. Recent studies reported that NK cells in the
inflammatory  sites  operate  through  the  Fas/FasL
interaction,  and  that  FasL  was  expressed  in  the
inflammatory sites.28 Interestingly mononuclear cells
co-expressed both Fas and FasL, suggesting that Fas/
FasL interactions may function in not only a paracrine
way, but also an autocrine way. This may be relevant
to the abnormal immune response in diseases.29
The  earliest  contact  between  antigen  and  the
innate  immune  system  is  thought  to  direct  the
subsequent  antigen-specific  T-cell  response.  It  has
been hypothesized that cells  of the innate immune
system, such as NK cells, NK1.1-positive T cells, and
gd T cells, may regulate the development of allergic
airway  disease.30 It  has  been  demonstrated  that
depletion  of  NK cells before  immunization  inhibits
pulmonary eosinophil and CD3-positive T-cell infiltra-
tion as well as increased levels of IL-4, IL-5, and IL-12
in bronchoalveolar lavage fluid in a murine model of
allergic asthma.31
We have reported that cells from induced sputum
from  patients  with  asthma  exhibited  an  increased
CD56+ cells within the gdT-cell population, which in
the majority is composed of A13+ cells. NK activity in
sputum from patients with asthma was mediated by
A13+ cells.  The  propensity  of  A13+ gd T  cells  to
accumulate  in  the  airway  of  patients  with  asthma
could  be  due to  the  better  migratory capacities of
these cells, as reported in other investigations.32,33An
increase of A13+ cells  has been  described in  other
inflammatory sites; it represents the major fraction of
intraepithelial T gd+ in the synovial fluid in rheuma-
toid arthritis.34 It was also reported in cerebrospinal
fluid, and in bronchoalveolar lavage of patients with
active Behçet’s disease.35 The present results report
that A13+ cells within the T gd population acted as
cells mediating NK activity, in sputum from patients
with asthma.
The  present  study  revealed  that  the  expression
levels of FasL mRNA was high. Similar results were
found in the liver,35 and the authors reported that this
situation is compatible with the conclusion that the
high  level  of  autologous  killing  in  TCRint cells  is
mediated by FasL/Fas molecules, but not perforin. The
FasL-mediated cytotoxicity may be acquired at more
mature stages of NK-cell maturation.36
An interesting recent study from Zuany-Amorin et
al.3 reported  that the  subset  of  gd T  cells  directly
involved in IL-4 production will represent an impor-
tant  step  for  understanding  and  modulating  the
development  of Th2  responses,  particularly  in  the
context of allergic diseases such as bronchial asthma.
A subset of gd T cells, positive for A13 monoclonal
antibody, in sputum from asthmatics acted as NK cells
through the FasL interaction. The knowledge of gd
T-cell  function  and  specificity  appears  to  be  an
important  component  of  asthma.  gd T  cells  have
proven biological activity in the lung.8 We therefore
hypothesize that gdT-cell activity elicited by infection
early in life accelerates the bias in gd T cells away for
Th2.8
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